Find latest Non-Small Cell Lung Cancer videos
·
500+ videos
Video Player is loading.
10 seconds
Playback speed
Advancements in Tumor-Agnostic Cancer Treatment: Expert Panel Discussion
Join leading oncologists Dr. Schneider, Dr. Peters, and Dr. Hendricks in an insightful Q&A session exploring the latest advancements in tumor-agnostic cancer treatment. This comprehensive video covers the integration of new therapies for non-small cell lung cancer (NSCLC), the transformative role of biomarker testing and liquid biopsies, and the global efforts to standardize treatment guidelines and improve access to care.
Key Topics:
• New FDA and EMA approvals for adjuvant and neoadjuvant therapies in early stage NSCLC
• Clinical applications and benefits of biomarker testing and liquid biopsies
• Challenges and strategies for global implementation of standardized lung cancer treatment guidelines
Access a downloadable transcript of this webinar at https://targeted-therapies-lung-cancer.ime.springerhealthcare.com/#qa
This is episode #4 of 4, and is part of an ACCME- and EACCME-accredited, Independent Medical Education program entitled, Biomarker-Positive Disease: A Personalized Approach to Selecting Targeted Therapies in Lung Cancer and Beyond.
To learn more about the full program or to CLAIM YOUR CREDITS, visit https://targeted-therapies-lung-cancer.ime.springerhealthcare.com/
---
This activity is supported by independent educational grants from Roche and Illumina.
Key Topics:
• New FDA and EMA approvals for adjuvant and neoadjuvant therapies in early stage NSCLC
• Clinical applications and benefits of biomarker testing and liquid biopsies
• Challenges and strategies for global implementation of standardized lung cancer treatment guidelines
Access a downloadable transcript of this webinar at https://targeted-therapies-lung-cancer.ime.springerhealthcare.com/#qa
This is episode #4 of 4, and is part of an ACCME- and EACCME-accredited, Independent Medical Education program entitled, Biomarker-Positive Disease: A Personalized Approach to Selecting Targeted Therapies in Lung Cancer and Beyond.
To learn more about the full program or to CLAIM YOUR CREDITS, visit https://targeted-therapies-lung-cancer.ime.springerhealthcare.com/
---
This activity is supported by independent educational grants from Roche and Illumina.
Comments 0
Login to view comments.
Click here to Login